109 related articles for article (PubMed ID: 5876862)
1. [Hypotensive drugs and tissue noradrenaline].
Jori A; Mortari A; Sioli G; Valzelli L
Boll Soc Ital Biol Sper; 1964 Nov; 40(22):1421-3. PubMed ID: 5876862
[No Abstract] [Full Text] [Related]
2. [Effect of 2-amino-4,5,6,7-tetrahydro-5-propyl-thiazole(5,4-c)pyridine, an antihypertensive and sedative substance, on the noradrenaline storage in the heart of guinea pigs].
Honjo T; Engelhardt G
Arzneimittelforschung; 1970 Jun; 20(6):845-50. PubMed ID: 5468901
[No Abstract] [Full Text] [Related]
3. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
Kroneberg G; Schlossmann K; Stoepel K
Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
[No Abstract] [Full Text] [Related]
4. [The effect of prolonged treatment of hypertensive rats with antihypertensive drugs of various actions on the arterial tension and noradrenaline level in the myocardium, brain and aortal].
Kiriakov A; Khlebarova M; Staneva-stoicheva D; Panova I
Eksp Med Morfol; 1975; 14(1):7-12. PubMed ID: 1218518
[TBL] [Abstract][Full Text] [Related]
5. [The effect of prolonged treatment hypertensive rats with antihypertensive agents with different mechanisms of action on blood pressure and noradrenaline concentration in the myocardium, brain and aorta].
Kiriakov A; Khlebarova M; Staneva-Stoicheva D; Panova I
Eksp Med Morfol; 1973; 12(3):135-41. PubMed ID: 4806527
[TBL] [Abstract][Full Text] [Related]
6. The influence of binazin on the levels of biogenic amines in the brain, heart, kidneys, and aorta of the experimental animals.
Billewicz-Stankiewicz J; Kleinrok HZ; Borzecki Z
Mater Med Pol; 1974; 6(3):183-7. PubMed ID: 4444333
[No Abstract] [Full Text] [Related]
7. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
Kaul CL; Grewal RS
Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
[No Abstract] [Full Text] [Related]
8. Central hypotensive effect of alpha-methyldopa.
Henning M; Van Zwieten PA
J Pharm Pharmacol; 1967 Jun; 19(6):403-5. PubMed ID: 4382373
[No Abstract] [Full Text] [Related]
9. [Antihypertensive and noradrenaline-depleting effect of alpha methyl tyramine and alpha methyl octapamine in the rat].
Maître L; Brunner H
Biochem Pharmacol; 1971 Feb; 20(2):351-9. PubMed ID: 5150136
[No Abstract] [Full Text] [Related]
10. [Inversion and disinversion in rabbits of some hypotensive agents similiar to adrenaline (tyramine, synephrine, neosynephrine, and dioxynorepinephrine)].
Hazard R; Mouillé P
C R Seances Soc Biol Fil; 1968; 162(2):342-5. PubMed ID: 4236608
[No Abstract] [Full Text] [Related]
11. Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine.
Thoenen H; Gerold M; Haefely W; Huerlimann A
Experientia; 1968 Feb; 24(2):158-9. PubMed ID: 4384506
[No Abstract] [Full Text] [Related]
12. [Catapressan metabolism. Hypotensive effect of 4-hydroxycatapressan].
Ehrhardt JD
Therapie; 1972; 27(5):947-54. PubMed ID: 4651414
[No Abstract] [Full Text] [Related]
13. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
Henning M
J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
[No Abstract] [Full Text] [Related]
14. Effect of neonatal 6-hydroxydopamine treatment on the blood pressure response to noradrenaline and tyramine in rats.
Provoost AP; de Kemp JA; de Jong W
Eur J Pharmacol; 1973 Sep; 23(3):297-301. PubMed ID: 4746745
[No Abstract] [Full Text] [Related]
15. Central hypotensive effect of alpha-methyldopa.
Henning M; van Zwieten PA
J Pharm Pharmacol; 1968 Jun; 20(6):409-17. PubMed ID: 4386523
[No Abstract] [Full Text] [Related]
16. A note on the subcellular distribution of adipose tissue noradrenaline.
Gesa GL; Congiu S; Spano PF; Musinu C
J Pharm Pharmacol; 1968 Feb; 20(2):132-4. PubMed ID: 4384536
[No Abstract] [Full Text] [Related]
17. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive and catecholamine-discharging effects of alpha-methyltyramine and alpha-methyloctopamine].
Maître L; Brunner H
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):40-1. PubMed ID: 4231853
[No Abstract] [Full Text] [Related]
19. [A comparative study of the distriution of 5-hydroxytryptamine and noradrenaline in different regions of the rat heart].
Weil-Fugazza J; Godefroy F
J Physiol (Paris); 1970; 62(3):245-54. PubMed ID: 5488487
[No Abstract] [Full Text] [Related]
20. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
